oncology | infill

infill - connecting healthcare professionals

A memo you do not want to miss

18 December 202018 December 2020 by Thorsten Land

Thorsten Land

767

Imagine you had access to a digital portal offering you digests of findings from the latest oncology and hematology clinical trials at the touch of a button. Indexed by event, you could download unbiased congress reports summarizing recent presentations at international oncology and hematology meetings such as ESMO, ASCO and…

Cancer care in COVID-19 times – sharing your learnings

4 August 202013 August 2020 by Vishal Hegde

Vishal Hegde

1478

Delivering cancer care in times of a pandemic is a challenge. Reduced hospital capacities and increased infection risks have had many impacts in the oncology world. Given that many cancer patients have to undergo tumour removal surgery and endure regular cycles of immunosuppressive chemo- and radiotherapy, cancer care at present…

A ray of hope

4 February 20204 February 2020 by Jenny Wilkinson

Jenny Wilkinson

2310

My interest in cancer began as a young scientist. I was fascinated by the genetic and cellular changes that give rise to cancers, and how we treat them based on these changes. I was aware that the goal in cancer research is saving lives, but I hadn’t started relating the…

Highlights from ESMO 2019

25 October 20196 December 2019 by Jenny Wilkinson

Jenny Wilkinson

1848

Nearly 30,000 delegates attended ESMO 2019, with many exciting and practice-changing studies presented. Here we bring you a taste of this years’ highlights, providing an insight into the plethora of recent trials which have led to significant survival and quality of life (QoL) gains for patients. PARP inhibition in ovarian…